The following is a guest article by Jason Warrelmann, Vice President, Global Services & Process Industries at UiPath
From battling COVID-19 surges to an increase in respiratory syncytial virus (RSV), and this year’s cold and…
Diagnostics company LumiraDx announced it signed an agreement to sell its point-of-care technology to pharma giant Roche for $295 million, with an additional payment of $55 million to fund the platform until the acquisition…
Continue Reading
Remote Patient Monitoring (RPM) stands as a pivotal innovation poised to reshape healthcare. Its effective implementation promises improved patient outcomes, streamlined clinician workflows, and enhanced healthcare accessibility. Through cutting-edge technology, RPM enables vital sign…
Continue Reading
This flu season will see at least 26 million cases, 290,000 hospitalizations, and 19,000 deaths, according to the U.S. Centers for Disease Control and Prevention. Pair that with a longstanding physician shortage and it…
Continue Reading
I’ve spent the majority of my career helping people use healthcare technology as efficiently as possible. It gets under my skin when clinicians report wildly inefficient workflows and I always want to dig in…
Continue Reading
In telehealth, diagnosing flu through patient-reported symptoms complicates accurate assessments. University of Georgia’s study explored clinical decision rules (CDRs) reliability in telemedicine, revealing discrepancies in patient and clinician symptom reports. The research, published in…
Continue Reading
Amazon Pharmacy announced Wednesday the launch of free drone delivery of prescription medications in 60 minutes or less for eligible customers in College Station, Texas. Over 500 medications for common conditions will be available via…
Continue Reading
Kate Behan, MD, FACP, Chief Medical Officer, Arcadia
A so-called “tripledemic” — the convergence of flu, RSV and COVID-19 — led to significant morbidity and mortality, and it also forced the cancellation or delay of…
Continue Reading
By Sara Heath
September 06, 2023 – Six in 10 adults over age 50 haven’t heard of RSV, or respiratory syncytial virus, and another 70 percent haven’t heard of the RSV vaccine most experts say could…
Continue Reading
NHS England has cancelled the contract with the supplier of the current national flu and Covid-19 vaccination system in favour of an alternative as yet unproven system. As a result, the National Immunisation Management Service…
Continue Reading
